SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-024416
Filing Date
2014-06-18
Accepted
2014-06-18 19:13:39
Documents
1
Period of Report
2014-06-17

Document Format Files

Seq Description Document Type Size
1 rrd412020.html 4  
1 rrd412020.xml 4 6938
  Complete submission text file 0001181431-14-024416.txt   8481
Mailing Address C/O SAGENT PHARMACEUTICALS, INC. 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address
FLANAGAN ROBERT J (Reporting) CIK: 0001251512 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35144 | Film No.: 14929147

Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Issuer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations